Call us 24/7

Advertising on our site helps support our mission. We do not endorse non-CTCA products or services.

Video: The promise of precision medicine

Precision medicine
When Christine Bray’s metastatic ovarian cancer didn’t respond to conventional treatments, her doctors tried something different.

When Christine Bray’s metastatic ovarian cancer didn’t respond to conventional treatments, her doctors at Cancer Treatment Centers of America® (CTCA) tried something different. A genomic sequencing test showed two mutations in Bray’s tumor that were targeted with a drug not typically used to treat ovarian cancer. Now researchers are using what they learned from her case to help other cancer patients with the same tumor mutations.

Watch the video to learn more about the promise of precision medicine.

 

Learn more about how doctors are decoding cancer's DNA